Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related radiographic damage to the axial or peripheral joints, new study reveals.

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

who specializes in psoriatic arthritis, rheumatoid arthritis and other musculoskeletal conditions. RA is an autoimmune disease, adds Bryant R. England, MD, PhD, an associate professor in the ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.